Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma

Experimental and Molecular Pathology

Volumn 86, Issue 2, 2009, Pages 108-113

  Hussein, Mahmoud Rezk A ^a   AL Assiri, Mana ^a   Musalam, Adel O ^a  

^a KING KHALID UNIVERSITY   (Saudi Arabia)

Author keywords

Carcinoma; Hyperplasia; Immune cells; Prostate

Indexed keywords

MONOCLONAL ANTIBODY;

ARTICLE; B LYMPHOCYTE; CELL COUNT; CELL DAMAGE; CELL DENSITY; CELL INFILTRATION; CELL POPULATION; CELLULAR IMMUNITY; HISTIOCYTE; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOHISTOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MALE; PHENOTYPE; PROSTATE; PROSTATE ADENOCARCINOMA; PROSTATE HYPERTROPHY; T LYMPHOCYTE;

ANTIGENS, CD; CELL COUNT; CELL MOVEMENT; HUMANS; IMMUNE SYSTEM; MALE; PHENOTYPE; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 62949162336     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2008.11.010     Document Type: Article

References (28)

1. Aalamian M., Pirtskhalaishvili G., Nunez A., Esche C., Shurin G.V., Huland E., Huland H., and Shurin M.R. Human prostate cancer regulates generation and maturation of monocyte-derived dendritic cells. Prostate 46 1 (2001) 68-75
2. Aalamian M., Tourkova I.L., Chatta G.S., Lilja H., Huland E., Huland H., Shurin G.V., and Shurin M.R. Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen. J. Urol. 170 5 (2003) 2026-2030
3. + T-cell apoptosis. Blood Cells Mol. Diseases 35 2 (2005) 169-173
4. Anim J.T., Udo C., and John B. Characterisation of inflammatory cells in benign prostatic hyperplasia. Acta Histochem. 100 4 (1998) 439-449
5. Bierhoff E., Vogel J., Benz M., Giefer T., Wernert N., and Pfeifer U. Stromal nodules in benign prostatic hyperplasia. Eur. Urol. 29 3 (1996) 345-354
6. Dannull J., Diener P.A., Prikler L., Furstenberger G., Cerny T., Schmid U., Ackermann D.K., and Groettrup M. Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer. Cancer Res. 60 19 (2000) 5522-5528
7. Di Carlo E., Magnasco S., D'Antuono T., Tenaglia R., and Sorrentino C. The prostate-associated lymphoid tissue (PALT) is linked to the expression of homing chemokines CXCL13 and CCL21. Prostate 67 10 (2007) 1070-1080
8. + lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma. Prostate 68 1 (2008) 1-10
9. Elsasser-Beile U., Przytulski B., Gierschner D., Grussenmeyer T., Katzenwadel A., Leiber C., Deckart A., and Wetterauer U. Comparison of the activation status of tumor infiltrating and peripheral lymphocytes of patients with adenocarcinomas and benign hyperplasia of the prostate. Prostate 45 1 (2000) 1-7
10. Gannon P.O., Alam Fahmy M., Begin L.R., Djoukhadjian A., Filali-Mouhim A., Lapointe R., Mes-Masson A.M., and Saad F. Presence of prostate cancer metastasis correlates with lower lymph node reactivity. Prostate 66 16 (2006) 1710-1720
11. Garcia-Hernandez Mde L., Gray A., Hubby B., Klinger O.J., and Kast W.M. Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity. Cancer Res. 68 3 (2008) 861-869
12. He J., and Baum L.G. Endothelial cell expression of galectin-1 induced by prostate cancer cells inhibits T-cell transendothelial migration. Lab. Invest. 86 6 (2006) 578-590
13. Hussein M.R., and Ahmed R.A. Analysis of the mononuclear inflammatory cell infiltrate in the non-tumorigenic, pre-tumorigenic and tumorigenic keratinocytic hyperproliferative lesions of the skin. Cancer Biol. Ther. 4 8 (2005) 819-821
14. Hussein M.R., and Ahmed R.A. Analysis of the mononuclear inflammatory cell infiltrate in the cirrhotic, dysplastic nodules and hepatocellular carcinomas in patients with chronic hepatitis C infection. Cancer Biol. Ther. 4 10 (2005) 1075-1078
15. Hussein M.R., and Hassan H.I. Analysis of the mononuclear inflammatory cell infiltrate in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas: preliminary observations. J. Clin. Pathol. 59 9 (2006) 972-977
16. Hussein M.R., Abou-Deif E.S., Bedaiwy M.A., Said T.M., Mustafa M.G., Nada E., Ezat A., and Agarwal A. Phenotypic characterization of the immune and mast cell infiltrates in the human testis shows normal and abnormal spermatogenesis. Fertil. Steril. 83 5 (2005) 1447-1453
17. Karja V., Aaltomaa S., Lipponen P., Isotalo T., Talja M., and Mokka R. Tumour-infiltrating lymphocytes: a prognostic factor of PSA-free survival in patients with local prostate carcinoma treated by radical prostatectomy. Anticancer Res. 25 6C (2005) 4435-4438
18. Mahapokai W., van den Ingh T.S., van Mil F., van Garderen E., Schalken J.A., Mol J.A., and van Sluijs F.J. Immune response in hormonally-induced prostatic hyperplasia in the dog. Vet. Immunol. Immunopathol. 78 3-4 (2001) 297-303
19. Matsuda M., Petersson M., Lenkei R., Taupin J.L., Magnusson I., Mellstedt H., Anderson P., and Kiessling R. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease. Int. J. Cancer 61 6 (1995) 765-772
20. McClinton S., Eremin O., and Miller I.D. Inflammatory infiltrate in prostatic hyperplasia-evidence of a host response to intraprostatic spermatozoa?. Br. J. Urol. 65 6 (1990) 606-610
21. McNeel D.G. Prostate cancer immunotherapy. Curr. Opin. Urol. 17 3 (2007) 175-181
22. Moser P.L., Brunner A., Horninger W., Bartsch G., and Mikuz G. Correlation between inflammatory cells (T and B lymphocytes, macrophages) in prostate biopsies and elevated PSA levels in a PSA screening population. Urology 59 1 (2002) 68-72
23. Mu L.J., Gaudernack G., Saeboe-Larssen S., Hammerstad H., Tierens A., and Kvalheim G. A protocol for generation of clinical grade mRNA-transfected monocyte-derived dendritic cells for cancer vaccines. Scand. J. Immunol. 58 5 (2003) 578-586
24. Neidhardt-Berard E.M., Berard F., Banchereau J., and Palucka A.K. Dendritic cells loaded with killed breast cancer cells induce differentiation of tumor-specific cytotoxic T lymphocytes. Breast Cancer Res. 6 4 (2004) R322-328
25. Steiner G., Gessl A., Kramer G., Schollhammer A., Forster O., and Marberger M. Phenotype and function of peripheral and prostatic lymphocytes in patients with benign prostatic hyperplasia. J. Urol. 151 2 (1994) 480-484
26. Theyer G., Kramer G., Assmann I., Sherwood E., Preinfalk W., Marberger M., Zechner O., and Steiner G.E. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia. Lab. Invest. 66 1 (1992) 96-107
27. Thomas J.W., Jerkins G., Cox C., and Lieberman P. Defective cell-mediated immunity in carcinoma of the prostate. Invest. Urol. 14 1 (1976) 72-75
28. Yang G., Addai J., Tian W.H., Frolov A., Wheeler T.M., and Thompson T.C. Reduced infiltration of class A scavenger receptor positive antigen-presenting cells is associated with prostate cancer progression. Cancer Res. 64 6 (2004) 2076-2082